Abstract:Objective To investigate the prevalence of frailty in elderly patients with congestive heart failure (CHF) and analyze its correlation with immune function. Methods Clinical data of 152 elderly CHF patients admitted to our hospital of Jiamusi University from January 2023 to December 2024 were retrospectively collected. Frailty was defined as a Fried frailty phenotype (FFP) score ≥3 points, and then these patients were divided into a frailty group and a non-frailty group. Left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD), N-terminal pro-B-type natriuretic peptide (NT-proBNP), 25-hydroxyvitamin D3 [25-(OH)D3], and immune function indicators [systemic immune inflammation index (SII), T lymphocyte subsets (CD4+, CD8+, CD4+/CD8+ ratio] were compared between two groups. Pearson correlation analysis was used to evaluate the correlation between FFP score and immune function in elderly CHF patients. Multivariate linear regression analysis was employed to further analyze the correlation after adjusting for confounding factors. The changes in immune function indicators at admission and discharge were recorded. All patients were followed up regularly after discharge. The incidence of unplanned readmission at 6 months after discharge was compared between two groups. SPSS statistics 25.0 was performed for statistical analysis. Data comparison between groups was applied using t test orχ2 test depending on data type. Results The prevalence of frailty was 53.29% (81/152) in the cohort. LVEF, 25-(OH)D3, CD4+ and CD4+/CD8+ were significantly lower, while LVEDD, NT-proBNP, SII and CD8+ were obviously higher in the frailty group than the non-frailty group (P<0.05). Pearson correlation analysis revealed that FFP score was negatively correlated with LVEF, 25-(OH)D3, CD4+ and CD4+/CD8+ (P<0.05), and positively with LVEDD, NT-proBNP, SII and CD8+ (P<0.05). Multivariate linear regression analysis found that, after adjusting for confounding factors such as gender, age and comorbidities, FFP score remained positively correlated with LVEDD (β=0.327,95%CI 0.103-0.592; P=0.008), NT-proBNP (β=0.362,95%CI 0.150-0.609; P=0.005), SII (β=0.289,95%CI 0.089-0.565; P=0.012) and CD8+ (β=0.307,95%CI 0.097-0.586; P=0.009), and was still negatively correlated with LVEF (β=-0.239,95%CI -0.486-0.032; P=0.015), 25-(OH)D3 (β=-0.208,95%CI -0.423--0.021; P=0.009), CD4+ (β=-0.231,95%CI -0.472--0.029; P=0.014) and CD4+/CD8+ (β=-0.224,95%CI -0.452--0.025; P=0.011). At discharge, SII and CD8+ in both the frailty group and non-frailty group were reduced compared with those at admission (P<0.05), while CD4+ and CD4+/CD8+ were increased than the baseline levels (P<0.05). At 6 months after discharge, the incidence rte of cardiac unplanned readmission (35.80% vs 21.13%) and total incidence of unplanned readmission (38.27% vs 22.54%) in the frailty group were statistically higher than those in the non-frailty group (P<0.05). Conclusion The prevalence of frailty in elderly CHF patients is severe, and frailty is significantly correlated with 25-(OH)D3 level, cardiac function and immune function. Frailty may increase the risk of unplanned readmission in elderly CHF patients. Active screening for frailty, monitoring 25-(OH)D3 level and implementation of targeted interventions may be beneficial for improving the clinical management of elderly CHF patients.